Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CSX Corporation (CSX) vs BIO-TECHNE Corp (TECH) Price & Performance

CSX CorporationTrade
BIO-TECHNE CorpTrade

Price performance (Past 24H)

Key statistics

CSX Corporation vs BIO-TECHNE Corp — how do they compare? CSX Corporation trades at $50 (market cap $92.24B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: CSX Corporation is far larger — about 8.3× BIO-TECHNE Corp's market cap, and CSX Corporation pays the higher dividend (1.13%). Which is the better fit depends on your goals.

CSXTECH
Market Cap
$92.24B$11.12B
Sector
IndustrialsHealth
52-Week High
$49.92$71.38
52-Week Low
$32.05$43.31
Enterprise Value
$110.47B$11.20B
Dividend Yield
1.13%0.45%

Returns comparison

Trailing returns across standard periods

About CSX Corporation

Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.

Read more on CSX

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Read more on TECH